E Fund Management Co. Ltd. Acquires Shares of 3,314 Agilent Technologies, Inc. $A

E Fund Management Co. Ltd. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 3,314 shares of the medical research company’s stock, valued at approximately $440,000.

A number of other large investors have also modified their holdings of the business. State Street Corp boosted its stake in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after buying an additional 241,029 shares in the last quarter. Geode Capital Management LLC raised its position in Agilent Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Deutsche Bank AG raised its position in Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after acquiring an additional 2,440,360 shares during the period. Finally, Morgan Stanley boosted its position in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after purchasing an additional 692,202 shares in the last quarter.

Agilent Technologies Trading Up 0.7%

Shares of Agilent Technologies stock opened at $156.50 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The business’s fifty day moving average is $136.98 and its two-hundred day moving average is $126.00. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm has a market cap of $44.20 billion, a PE ratio of 31.43, a P/E/G ratio of 2.75 and a beta of 1.25.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the firm posted $1.31 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on A. HSBC cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Sanford C. Bernstein started coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 target price on the stock. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.